The isoprostane, 8-epi-PGF(2α), is accumulated in coronary arteries isolated from patients with coronary heart disease

Cardiovascular Research

Volumn 43, Issue 2, 1999, Pages 492-499

  Reza Mehrabi, Mohammad ^a   Ekmekcioglu, Cem ^a   Tatzber, Franz ^a   Oguogho, Anthony ^a   Ullrich, Robert ^a   Morgan, Abdelmonem ^a   Tamaddon, Forouzan ^a   Grimm, Michael ^a   Glogar, Helmut D ^a   Sinzinger, Helmut ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Atherosclerosis; Cardiomyopathy; Coronary disease; Free radicals; Prostaglandins

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ISOPROSTANE; PROSTAGLANDIN;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTIMA; ISCHEMIC HEART DISEASE; MALE; PEROXIDATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ANALYSIS OF VARIANCE; CARDIOMYOPATHY, DILATED; CORONARY DISEASE; CORONARY VESSELS; HEART TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; RADIOIMMUNOASSAY;

EID: 0345551966     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00108-X     Document Type: Article

References (27)

1. Thomas H.E. Jr., Kannel W.B., Dawber T.R., McNamara P.M. Cholesterol-phospholipid ratio in the prediction of coronary heart disease. The Framingham study. N Engl J Med. 274:1966;701-705.
2. Castelli W.P. Lipids, risk factors and ischaemic heart disease. Atherosclerosis. 124:1996;S1-S9.
3. Steinberg D. Clinical trials of antioxidants in atherosclerosis: are we doing the right thing? Lancet. 346:1995;36-38.
4. Esterbauer H., Wag G., Puhl H. Lipid peroxidation and its role in atherosclerosis. Br Med Bull. 49:1993;566-576.
5. 2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA. 89:1992;10721-10725.
6. Morrow J.D., Harris T.M., Robers L.J. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: Analytical ramifications for measurement of eicosanoids. Anal Biochem. 184:1990;1-10.
7. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA. 87:1990;9383-9387.
8. Reilly M., Delanty N., Lawson J.A., FitzGerald G.A. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation. 94:1996;19-25.
9. 2 isoprostanes, are present in increased amounts in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 17:1997;3236-3241.
10. Pratico D., Iuliano L., Mauriello A., et al. Localization of distinct F-2-isoprostanes in human atherosclerotic lesions. J Clin Invest. 100:1997;2028-2034.
11. 2 alpha is increased in hypercholesterolemia. Arterioscler Thromb Vasc Biol. 17:1997;3230-3235.
12. Patrono C., FitzGerald G.A. Isoprostanes. Potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol. 17:1997;2309-2315.
13. Kromer B.M., Tippins J.R. Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha. Br J Pharmacol. 119:1996;1276-1280.
14. Human experimentation. Code of ethics of the World Medical Association and statement on responsibility in investigations on human subjects. Br Med J. 2:1964;177-180.
15. Wang Z., Ciabattoni G., Créminon C., et al. Immunological characterization of urinary 8-epi-Prostaglandin F2 alpha excretion in man. J Pharmacol Exp Ther. 275:1995;94-100.
16. Morrow J.D., Roberts L.J. The Isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res. 36:1997;1-21.
17. Pratico D., Reilly M., Lawson J.A., FitzGerald G.A. Novel indices of oxidant stress in cardiovascular disease: specific analysis of F2-isoprostanes. Agents Actions Suppl. 48:1997;25-41.
18. Delanty N., Reilly M., Pratico D., et al. 8-Epi PGF2 alpha: specific analysis of an isoeicosanoid as an index of oxidant stress in vivo. Br J Clin Pharmacol. 42:1996;15-19.
19. 2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite. Circ Res. 77:1995;335-341.
20. Bachi A., Zuccato E., Baraldi M., Fanelli R., Chiabrando C. Measurement of urinary 8-epi-prostaglandin F2alpha, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction/gas chromatography-mass spectrometry. Basal levels in smokers and nonsmokers. Free Radic Biol Med. 20:1996;619-624.
21. FitzGerald G.A. Isoprostanes-indices of oxidant stress. Fibrinolysis. 10:1996;37-38.
22. Reilly M.P., Barry P., Lawson J.A., FitzGerald G. Urinary 8-epi PGF(2alpha): An index of oxidant stress in vivo. Fibrinolysis Proteolysis. 11:(Suppl.1):1997;81-84.
23. Young W., Gofman J.W., Tandy R., Malmud N., Waters E.S.G. The quantitation of atherosclerosis. III. The extent of correlation of degrees of atherosclerosis within and between the coronary and cerebral vascular beds. Am J Cardiol. 6:1960;300-308.
24. Mitchell J.R.A., Schwartz C.J. Relationship between arterial disease in different sites: a study of the aorta and coronary, carotid, and iliac arteries. Br Med J. 5288:1962;1293-1301.
25. Adams M.R., Nakagomi A., Keech A., et al. Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation. 92:1995;2127-2134.
26. 2α by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2. J Biol Chem. 271:1996;8919-8924.
27. 2α in pericardial fluid of patients with heart failure. Circulation. 97:1998;1536-1539.